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Introduction 
There is a growing prima facie case for inflammation being a determinant of suicide.  In 
cohort studies, elevated levels of inflammatory markers have been linked to the future 
occurrence of depression,1  a known risk factor for suicide.  In psychiatric patients, 
inflammation is positively correlated with  the intensity of self-reported suicidal ideation2 
and, post mortem, relative to controls, victims of suicide have higher cytokine levels.3  
Furthermore, individuals with asthma, a condition characterised by inflammation, experience 
higher rates of suicide mortality than non-atopic counterparts.4    
 
While these various lines of evidence may implicate inflammation in the pathophysiology of 
suicide, there has been no prospective examination of the link between inflammation and 
future suicide events.   
 
Methods 
Data from a series of independent, geographically-representative, near-identical surveys of 
individuals living in private households, conducted between 1998 and 2006 in the UK, were 
pooled.5  In seven (1998, 1999, 2003, 2004, 2006 Health Survey for England [HSE]; 1998, 
2003 Scottish Health Survey [SHS]), serum CRP was ascertained using the N-Latex CRP 
mono-immunoassay on the Behring Nephelometer II Analyser.  Study members were linked 
to national cause-of-death registers until 14th February 2011 (HES) or 31st December 2009 
(SHS).  Death certification for suicide has a high level of agreement with other sources of 
evidence (forensic reports, police reports, toxicological and histological data).6  Covariates 
included psychological distress which comprised ‘caseness’ on 12-item General Health 
Questionnaire, self-reported long-standing mental illness, and use of psychotropic 
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medication.  Ethical approval for each survey was granted by local Research Ethics 
Committees, and study members provided informed consent.    
 
Results 
A mean duration of 8.6 years of follow-up (339,727 person-years) gave rise to 26 deaths 
ascribed to suicide (7.7 events per 100,000 person-years) in an analytical sample with data on 
inflammation, age, sex, and mortality (N=39,349).  Of the study covariates, cigarette smoking 
(age- and gender-adjusted hazard ratio; 95% confidence interval: current vs. never/former: 
9.67; 3.82, 24.52), gender (male vs. female: 2.64; 1.15, 6.07), socioeconomic status (manual 
social class vs. non-manual: 4.02; 1.60, 10.13), and psychological distress (‘caseness’ vs. not: 
4.89; 2.22, 10.80) were related to an elevated rate of suicide.   
 
After basic adjustment, people in the highest inflammation group were four times more likely 
to die from suicide relative to those in the lowest group (4.20; 1.44, 12.25) (table 1).  A 
graded association was apparent across the three categories (p-value[trend]=0.007) with a 1-
SD-increase in inflammation associated with a 55% increase in suicide risk (1.55; 1.05-2.30).  
This gradient was attenuated somewhat after adjustment for smoking, although accounting 
for other covariates had little impact.   
 
Excluding people at various thresholds of high CRP (4, 6, 8, 10 mg/L) did not materially alter 
our findings.  While a positive association between CRP and suicide rates was apparent 
across the full duration of follow-up (figure 1), on partitioning (<=5 vs. >5 years), the 
magnitude of this relationship was somewhat stronger in the early (multivariable-adjusted 
hazard ratio for a 1-SD increase in CRP: 1.63; 0.87, 3.05) relative to the later phases (1.17; 
0.69, 1.96).  
4 
 
 
Discussion 
We found up to a 4-fold increased risk of completed suicide in individuals with elevated 
inflammation compared with those having low levels.  That this gradient was not explained 
by controlling for a series of covariates raises the likelihood that other mechanisms underlie 
the association.  Our finding that suicide was related to a series of known risk factors gives us 
some confidence in our novel results for inflammation.    
 
Despite a large sample size, the number of completed suicide cases herein was modest 
leading to low statistical power.  Our results therefore warrant testing using the present study 
design and other approaches such as Mendelian Randomisation and large-scale 
pharmacological trials of inflammation reduction.   
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Table 1. Hazard ratios (95% CI) for the association of C-reactive protein with completed suicide: 
pooling of data from seven UK general population-based longitudinal studies 
 
 N 
events 
N 
at risk 
C-reactive protein P-value 
for trend 
1 SD 
increase in 
CRP 
   Low 
(<1mg/L) 
Intermediate 
(1-3mg/L) 
High 
(>3mg/L) 
  
N of events / N at risk 
 
26 39349 5 / 14241 9 / 13660 12 / 11448   
Age- and sex-adjusted 26 39349 1.0 (ref.) 2.16 
(0.71, 6.51) 
4.20 
(1.44, 12.25) 
0.007 1.55 
(1.05, 2.30) 
Age-, sex-, and socioeconomic 
status-adjusted 
26 37392 1.0 2.09  
(0.69, 6.32) 
3.86  
(1.32, 11.32) 
0.01 1.50  
(1.01, 2.23) 
Age-, sex-, and somatic illness-
adjusted 
26 39339 1.0 2.15  
(0.71, 6.50) 
4.16  
(1.42, 12.18) 
0.007 1.55  
(1.04, 2.29) 
Age-, sex-, and psychological 
distress-adjusted 
25 38114 1.0 2.60  
(0.79, 8.52) 
4.56  
(1.43, 14.55) 
0.008 1.53  
(1.03, 2.29) 
Age-, sex- and smoking-
adjusted 
26 39200 1.0 1.83  
(0.60, 5.54) 
3.03  
(1.03, 8.94) 
0.04 1.36  
(0.91, 2.03) 
Multivariable-adjusted 25 36267 1.0 2.23  
(0.68, 7.35) 
3.31  
(1.02, 10.73) 
0.04 1.33  
(0.89, 2.01) 
 
Multivariable adjustment is adjustment for age, sex, socioeconomic status, psychological distress, cigarette smoking, and somatic illness  
(neoplasms, diabetes, other endocrine disorders, cerebrovascular disease, myocardial infarction, angina, hypertension,  
any other heart disease, respiratory diseases and any other non-mental health condition). 
 
Suicide mortality was denoted by any mention of the following events on death certificates (international classification of  
diseases (ICD) 9th and 10th revisions): ICD-9 suicide and self-inflicted poisoning by solid or liquid substances (E950-E959)  
and injury undetermined whether accidentally or purposely inflicted (E980-E989), and ICD-10 terrorism (U03.1 and U03.9),  
intentional self-harm (X60-X84), event of undetermined intent (Y10-Y34), sequelae of intentional self-harm, assault and  
events of undetermined intent (Y87), and sequelae of unspecified external cause (Y89.9).   
 
For the computation of hazard ratios per 1-SD-increase in CRP, CRP data were log-transformed (loge[CRP] 1.25).  
 
In all analyses the baseline hazard function was stratified by study.   
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Figure 1. Suicide death rates according to CRP level and duration of follow-up:   
pooling of data from seven UK general population-based longitudinal studies 
 
 
Legend:  The figure displays the proportion of deaths by suicide (each ‘step’ signals at least 
one event) in each of the three CRP categories (Low [<1mg/L], Intermediate [1-3mg/L], 
High [>3mg/L]) over the duration of follow-up (0-17 years).   
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